Literature DB >> 9079903

Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr.

K A Klyachko1, S Schuldiner, A A Neyfakh.   

Abstract

The Bacillus subtilis multidrug transporter Bmr, a member of the major facilitator superfamily of transporters, causes the efflux of a number of structurally unrelated toxic compounds from cells. We have shown previously that the activity of Bmr can be inhibited by the plant alkaloid reserpine. Here we demonstrate that various substitutions of residues Phe143 and Phe306 of Bmr not only reduce its sensitivity to reserpine inhibition but also significantly change its substrate specificity. Cross-resistance profiles of bacteria expressing mutant forms of the transporter differ from each other and from the cross-resistance profile of cells expressing wild-type Bmr. This result strongly suggests that Bmr interacts with its transported drugs directly, with residues Phe143 and Phe306 likely to be involved in substrate recognition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9079903      PMCID: PMC178954          DOI: 10.1128/jb.179.7.2189-2193.1997

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  18 in total

1.  A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.

Authors:  P Gros; R Dhir; J Croop; F Talbot
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.

Authors:  A A Neyfakh; V E Bidnenko; L B Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 3.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

Review 4.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

5.  Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine.

Authors:  M Ahmed; C M Borsch; A A Neyfakh; S Schuldiner
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

7.  Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids.

Authors:  K Timmers; R Sternglanz
Journal:  Bioinorg Chem       Date:  1978-08

8.  Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.

Authors:  A A Neyfakh; C M Borsch; G W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

9.  An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.

Authors:  K H Choi; C J Chen; M Kriegler; I B Roninson
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

10.  Diversity of multidrug resistance in mammalian cells.

Authors:  S E Devine; P W Melera
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

View more
  24 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 2.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Structure of the multidrug transporter EmrD from Escherichia coli.

Authors:  Yong Yin; Xiao He; Paul Szewczyk; That Nguyen; Geoffrey Chang
Journal:  Science       Date:  2006-05-05       Impact factor: 47.728

4.  Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.

Authors:  Céline Vidaillac; Jean Guillon; Corinne Arpin; Isabelle Forfar-Bares; Boubakar B Ba; Jean Grellet; Stéphane Moreau; Daniel-Henri Caignard; Christian Jarry; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

Review 5.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

6.  Paradoxical enhancement of the activity of a bacterial multidrug transporter caused by substitutions of a conserved residue.

Authors:  K A Klyachko; A A Neyfakh
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

7.  Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.

Authors:  P N Markham; E Westhaus; K Klyachko; M E Johnson; A A Neyfakh
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

8.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.

Authors:  Jocelyn K Middlemiss; Keith Poole
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

Review 10.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.